EMJ Podcast: Benefits of Neoadjuvant use of Mitomycin C for the Management of NMIBC
This episode, sponsored by medac, is a discussion around non-muscle-invasive bladder cancer (NMIBC). We hear from Professor Jørgen Bjerggaard Jensen as he explores the management of NMIBC through the neoadjuvant use of Mitomycin C (MMC).